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Background: Preoperative assessment is critical to decide the most adequate surgical
strategy for oral squamous cell carcinoma (SCC). Magnetic resonance (MR) and intraoral
ultrasonography (US) have been reported to be of great value for preoperative estimation
of depth of invasion (DOI) and/or tumor thickness (TT). This review aims to analyze
the accuracy of MR and intraoral US in determining DOI/TT in oral SCC, by assuming
histological evaluation as the reference method.
Methods: The procedure was conducted following the modified 2009 Preferred
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. We
performed a systematic search of papers on PubMed, Scopus, Web of Science, and
Cochrane Library databases until July 31st, 2019. For quantitative synthesis, we included
nine studies (487 patients) focused onMR, and 12 (520 patients) focused on intraoral US.
The Pearson correlation coefficient (r) between DOI/TT evaluated with MR or intraoral US
was assumed as effect size. A meta-analysis (MA) for each study group (MR and US) was
performed by using the random-effects models with the DerSimonian–Laird estimator
and r-to-z transformation.
Results: In the MA for MR studies, a high heterogeneity was found (I2 = 94.84%; Q
= 154.915, P < 0.001). No significant risk of bias occurred by evaluating funnel plot
asymmetry (P = 0.563). The pooled (overall) r of the MR studies was 0.87 (95% CI from
0.82 to 0.92), whereas the pooled r-to-z transformed was 1.44 (95% CI from 1.02 to
1.85). In the MA for US studies a high heterogeneity was found (I2 = 93.56%; Q =
170.884, P < 0.001). However, no significant risk of bias occurred (P = 0.779). The
pooled r of the US studies was 0.96 (95% CI from 0.94 to 0.97), whereas the pooled
r-to-z transformed was 1.76 (95% CI from 1.39 to 2.13). These outputs were confirmed
in additional MA performed by enrolling only MR (n = 8) and US (n = 11) studies that
evaluated TT.
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Conclusions: MR and intraoral US seem to be promising approaches for preoperative
assessment of DOI/TT in oral SCC. Remarkably, a higher pooled r and r-to-z transformed
were observed in the intraoral US studies, suggesting that this approach could be more
closely related to histopathological findings.
Keywords: oral cavity, squamous cell cancer (SCC), magnetic resonance imaging (MRI), ultrasound, depth of
invasion (DOI), tumor thickness
INTRODUCTION
Head and neck tumors are the sixth most common malignancies
worldwide, of which oral cavity accounts for one-third (1). Most
of these lesions are represented by squamous cell carcinoma
(SCC), and their commonest site of presentation is the mobile
tongue, followed by lips vermilion, floor of the mouth, and buccal
mucosa. The vast majority of patients are male, heavy smokers,
and with a history of alcohol abuse.
The recently released 8th edition of the AJCC-UICC TNM
staging system (2, 3) brought relevant changes in the T
classification of oral SCC. Notably, it introduced the concept of
neoplastic depth of invasion (DOI) as one of the main features to
be considered in the process of tumor staging. DOI is defined as
“the deepest invasion of tumor in the tissue from the mucosal
surface or from a theoretical reconstructed normal mucosal
line” (3). It therefore differs in a fundamental way from tumor
thickness (TT), since the latter is defined as the distance of
the tumor surface from the deepest level of invasion (4). As a
consequence of this, DOI can be significantly lower than TT in
exophytic lesions, while it tends to be higher in ulcerated ones.
On the other hand, the two measures may overlap each other in
case of substantially flat tumors.
The intrinsic value of DOI for understanding the biologic
behavior of a given oral SCC is of paramount importance in
predicting regional lymph node metastasis. That being the case,
identifying which radiological examination performs best in
giving a precise preoperative assessment of DOI is of the greatest
value. In fact, even though definitive DOI estimation will derive
only from measures done on the formalin-fixed specimen (per se
also subjected to unpredictable variations in terms of shrinkage
due to the elastic properties of soft tissues and the process of
chemical fixation itself), having a precise preoperative evaluation
of this parameter allows the surgeon to accurately plan the
resection, as well as simultaneous prophylactic neck dissection
(for oral SCC with DOI > 4mm). Moreover, the concept
of adequate surgery within three-dimensional free resection
margins cannot be overemphasized: in fact, it also represents
an essential treatment-related prognosticator in terms of local,
loco-regional control, and disease-free survival (5).
The standard diagnostic workup for oral SCC includes
head and neck magnetic resonance (MR) and chest computed
tomography (CT) scan in order to acquire a comprehensive
TNM staging of the lesion. In the last decades, data from the
literature showed a promising role of intraoral ultrasonography
(US) in the preoperative evaluation of TT and/or DOI of a given
lesion (6). The aim of the present review and meta-analysis was
therefore to identify the best radiological examination (MR vs.
intraoral US) to be offered to patients affected by oral SCC, to
assess tumor clinical staging, and, consequently, to tailor the best
surgical treatment in terms of oncological outcomes and minor
ensuing comorbidities.
MATERIALS AND METHODS
We adhered to the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guidelines (7). The
PRISMA checklist for this study is reported in Table S1. We
registered our protocol with the International Prospective Register
of Systematic Reviews (PROSPERO) (PROSPERO registration
number: 102553).
Search Strategy
We performed a systematic search on PubMed, Scopus, Web
of Science, and Cochrane Library databases of papers published
from January 1st, 1978, until July 31st, 2019, with the combined
query “(MR OR magnetic resonance) and (oral cavity OR head
and neck) and (cancer OR tumor OR carcinoma) and (thickness
OR depth of invasion OR depth of infiltration)” and “(US OR
ultrasonography) and (oral cavity OR head and neck) and (cancer
OR tumor OR carcinoma) and (thickness OR depth of invasion
OR depth of infiltration),” and their synonyms in the title and
abstract fields (more details about searching and queries are
reported in Table S2). Subsequently, the full text of relevant
studies was screened for final selection. The references in all
studies included were also searched to identify further potentially
eligible studies. When multiple publications of the same research
group/center described case series potentially overlapping, we
used the more recent publication, if eligible.
Eligibility Assessment
All studies identified by the initial literature search were reviewed
independently by three authors (MF, FM, and ALCC). All
titles and abstracts were assessed and, when in doubt, the
full text scrutinized. If a dispute remained, this was resolved
by one of the senior authors (GP). Inclusion criteria for
evaluation of tumor DOI or TT with MR were: patients
affected by oral SCC confirmed at histopathology, preoperative
measurement of DOI and/or TT by MR, and comparison
with histopathological DOI and/or TT. Inclusion criteria for
evaluation of tumor DOI with US were: patients affected
by histopathologically confirmed oral SCC, preoperative or
intraoperative measurement of DOI and/or TT performed by
intraoral US, and comparison with histopathological DOI and/or
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TT. Exclusion criteria were: duplicated articles, book chapters,
case reports, poster presentations, articles analyzing different
head and neck malignancies or other subsites rather than oral
cavity, and articles in a language other than English (7).
Appraisal of Study Quality
Risk of bias of each included study was assessed by using the
Quality Assessment of Diagnostic Accuracy Studies (QUADAS)-
2 tool (8). The overall quality of evidence at the outcome level
was assessed according to the Grading of Recommendations,
Assessment, Development and Evaluations (GRADE) system (9).
Four reviewers were contents experts (FM, MF, AC, GP), and
one reviewer (GS) was an expert statistician. The contents
experts only assessed potential publications with respect to
the appropriateness of the research questions. The statistician
only evaluated the appropriateness of methods employed.
Disagreement was resolved by consensus.
Data Extraction
Data extraction included the following fields: study
(conventionally reported with the first author), year of
publication, mode of patient recruitment, country, number
of patients, gender, age, tumor site, TNM staging according to
the 7th edition of the AJCC-UICC staging system for oral SCC
(10, 11), intraoral US device and type of probe, MR device, linear
correlation between intraoral US and histopathology, and linear
correlation between MR and histopathology (Table S3).
Statistical Analysis
The statistical heterogeneity among studies was expressed as τ 2
and estimated by Cochrane’s Q test (11). The I2 was calculated to
assess variability due to heterogeneity rather than chance (I2 ≤
25%: low; I2 > 25% and ≤50%: moderate; I2 > 50% and ≤75%:
considerable; I2 > 75%: high heterogeneity). H2 was the ratio
between total and sampling variability. For both I2 and H2, the
95% confidence interval (CI) was calculated.
The meta-analysis was carried out by assuming the Pearson
correlation coefficient (r) between MR or US and TT/DOI
measurements on incisional biopsies (“gold standard”) as the
effect size. Considering that in themajority of enrolled studies the
TT was assessed with MR or US, we performed a further meta-
analysis to evaluate only the outcomes of the TT-related studies.
The DerSimonian–Laird estimator was used in the random-
effects models (12) with Fisher’s r-to-z transformation. Forest
plots were created for each measured outcome to illustrate the
effects of the different studies and the global estimation. In the
random-effects models, the selected studies and their outcomes
are assumed to be a random selection from a larger population of
studies. The random-effects models were evaluated for each effect
size without and with moderator variables; in the latter case, we
obtained the corresponding mixed-effects models (one model for
each moderator), where the coefficients from the fitted models
estimate the relationship between the average true effect/outcome
in the population of studies and the moderator variables included
in the same models. The Knapp and Hartung method was used
to adjust the standard errors of the estimated coefficients, which
helps to account for the uncertainty in the estimate of residual
heterogeneity. When moderators were included in the models,
the QE-test was used to evaluate residual heterogeneity.
The publication bias related to data asymmetry was estimated
by funnel plots and Egger’s test (13). For further evaluation
of heterogeneity in each model, we evaluated also radial plots
(14), normal quantile–quantile (Q-Q) plots (15), and Baujat
plots (16). Statistical significance was assumed in each test with
P < 0.05. Statistical analysis was carried out by using the R
software/environment (version 3.6.1; R Foundation for Statistical
Computing, Vienna, Austria), with the metafor (version 2.1-0)
(17) and metacor (version 1.0-2) (18) R packages.
RESULTS
Literature Search and Study Identification
for MR
An overview of our selection process for MR-related studies is
presented in Figure 1A. An initial keyword search of the listed
databases identified 11,193 records. After duplicate removing and
after excluded records in titles and abstracts, 43 full-text articles
were assessed for eligibility (Table S4A). Of these, nine were
deemed eligible for inclusion in the meta-analysis.
Literature Search and Study Identification
for Intraoral US
An overview of our selection process for US-related studies is
presented in Figure 1B. An initial keyword search of the listed
databases identified 17,402 records. After duplicate removing
and after excluded records in titles and abstracts, 17 full-text
articles were assessed for eligibility (Table S4B). Of these, 12 were
deemed eligible for inclusion in the meta-analysis. The study
by Yesuratnam et al. (19) was conducted performing MR and
intraoral US simultaneously on each patient recruited and, for
this reason, was included in both arms of the meta-analysis.
Characteristics of Included MR Studies
The studies included in the meta-analysis are summarized in
Table 1. All studies compared TT or DOI measured by MR with
TT or DOI measured on histopathological slides. A total of 9
studies (n = 487 patients) was included (19–27). Sample size
ranged from 18 to 102 patients. The articles were published over
a period of 14 years (2003–2017). Patient recruitment ranged
from 1997 to 2016. The studies showed a wide geographical
distribution, the most substantial contributions coming from
Asian countries (six studies). Among the participants included
in the present meta-analysis, a significant male preponderance
(72%) was observed. Average age was 55.5 years (range, 49–63.5).
Six studies included patients affected by T1–T4 oral SCC (19–
21, 23, 24, 26), one recruited T1–T2 lesions (25), one enrolled
T1–T3 tumors (27), and one selected patients with advanced
lesions (only T4a) (22). Nodal categories ranged from N0 to N3.
The most frequently analyzed oral cavity subsite was the oral
tongue (six studies) (19, 20, 22, 23, 25, 27), while three papers
described oral SCC from different subsites (21, 24, 26). All the
selected studies had good linear correlation between MR and
histopathology. The Pearson r ranged from 0.63 to 0.99. MR was
performed in six studies with a 1.5 Tesla (T) scanner, while in
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FIGURE 1 | Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram of the search results for original studies related to magnetic
resonance (A) and ultrasonography (B).
three with a 3.0 T scanner. Eight studies reported TT measured
on MR: six of them specified also the mean value of TT (range,
8.4–25.9mm; mean, 14.4mm) (20–23, 26, 27), while the others
only declared the Pearson r (19, 24). One study reported DOI
measured on MR presenting only the value of Pearson r (25).
Five studies calculated the overestimation ofMR compared to the
histopathology reports (mean, 2.5mm) (19–21, 23, 27).
Characteristics of Intraoral US Included
Studies
The studies included in the meta-analysis are summarized
in Table 2. All studies compared TT or DOI measured
preoperatively or intraoperatively by intraoral US with TT or
DOI measured on histopathological slides. A total of 12 studies
(n = 520 patients) was included (19, 28–38). The sample size
ranged from 13 to 109 patients. The articles were published over a
period of 17 years (2001–2018), and patient recruitment covered
the period 1997–2016. The studies showed a wide geographical
distribution, but also, for intraoral US, the most substantial
contributions came from Asian countries, in particular, from
Japan (six studies) (28, 31, 33, 35, 37, 38). There was a moderate
male preponderance (59%) among the participants included in
this analysis. The mean age was 60.3 years (range, 57–65). Seven
studies included patients affected by T1–T4 oral SCC (19, 28,
29, 32, 36–38), and five recruited T1–T2 tumors (30, 31, 33–35).
Nodal categories ranged from N0 to N3. The most frequently
analyzed oral cavity subsite was the oral tongue (eight studies)
(19, 28, 29, 31, 33–35, 37), while four papers described oral
SCC from different subsites (30, 32, 36, 38). All the studies
selected had a good linear correlation between intraoral US and
histopathology. The Pearson r ranged from 0.83 to 0.99. The
probe frequency (PF) used for intraoral US ranged from 5 to
16 MHz. Eleven studies reported TT measured by intraoral US
(range, 3.8–16mm; mean, 9.4mm) (19, 29–38). Among these,
eight also calculated the overestimation of intraoral US compared
to the histopathology reports (mean, 1.7mm) (19, 28–31, 34, 37,
38). One study reported DOI measured by intraoral US (28).
Quality Assessment and Risk of Bias
The risk of bias evaluated with the QUADAS-2 tool for the
included MR-related studies was low in three studies (22, 23, 25),
unclear in three (20, 21, 27), and high in three (19, 24, 26)
(Table 3). The risk of bias evaluated with the QUADAS-2 tool
for the included US-related studies was low in one study (36),
unclear in seven (28, 29, 31–35), and high in four (19, 30, 37, 38)
(Table 3). Following the GRADE system, the overall quality of
evidence for the included studies related to MR and intraoral US
was assessed as very low (Tables S5A,B).
Meta-Analysis for Studies Related to MR
In the random-effects model with all MR studies (n= 9) included
(MR1 model), the I2 was 94.84% (95% CI, 85.67–98.18), and
the H2 was 19.36 (95% CI, 6.98–55.06), with Q = 154.915 (P
< 0.001). The pooled r was 0.87 (95% CI, 0.82–0.92), whereas
the pooled r-to-z transformed was 1.44 (95% CI, 1.02–1.85).
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TABLE 1 | Characteristics of included studies related to magnetic resonance.







Moreno et al. (20) US 2009–2012 Prospective 25 58 68% Tongue T1–T4 0–2 3 T 0.84
Goel et al. (21) India 2013–2015 Prospective 61 49 74% Oral cavity T1–T4 0–2 1.5 T 0.988
Yesuratnam et al. (19) Australia 2007–2012 Prospective 81 63 58% Tongue T1–T4 0 3 T 0.69
Chen et al. (22) Taiwan 2003–2006 Prospective 58 50.7 93% Tongue T4a - 1.5 T 0.905
Park et al. (23) Korea 2003–2008 Retrospective 49 54.6 78% Tongue T1–T4 0–2 1.5 T 0.949
Lwin et al. (24) UK 2007–2008 Retrospective 102 59 67% Oral cavity T1–T4 0–2 1.5 T 0.63
Jung et al. (25) Korea 2002–2005 Retrospective 50 52 52% Tongue T1–T2 0 3 T 0.851
Okura et al. (26) Japan 1998–2007 Retrospective 43 58 67% Oral cavity T1–T4 0–3 1.5 T 0.86
Lam et al. (27) Hong Kong 1997–2000 Prospective 18 63.5 88% Tongue T1–T3 0–1 1.5 T 0.938
MR, magnetic resonance.
TABLE 2 | Characteristic of included studies related to intraoral ultrasonography.








T N US probe Setting Pearson
(r)
Iida et al. (28) Japan 2008–2015 Retrospective 56 59 61% Tongue 1–4 0 16 MHz Preoperative 0.86
Yesuratnam et al. (19) Australia 2007–2012 Prospective 88 63 58% Tongue 1–4 0 15–5 MHz Preoperative 0.8
Chammas et al. (29) Brazil 2006–2009 Prospective 19 60 58% Tongue 1–4 1–3 5–10 MHz Preoperative 0.83
Lodder et al. (30) Netherlands 2004–2010 Retrospective 65 65 52% Tongue/Fom 1–2 0–2 7–15 MHz Intraoperative 0.93
Kodama et al. (31) Japan 2005–2007 Prospective 13 61,6 62% Tongue 1–2 0 7.5 MHz Intraoperative 0.981
Mark Taylor et al. (32) Canada - Prospective 21 65 57% Tongue/Fom 1–4 0–2 10–12 MHz Preoperative 0.981
Kaneoya et al. (33) Japan - Prospective 48 57 56% Tongue 1–2 0 12 MHz Intraoperative 0.824
Baek et al. (34) South Korea 2006–2007 Prospective 20 57 50% Tongue 1–2 0 8–10 MHz Intraoperative 0.744
Yamane et al. (35) Japan 1998–2002 Prospective 109 57 70% Tongue 1–2 0 10 MHz Preoperative 0.985
Songra et al. (36) United Kingdom 1997–2002 Prospective 14 - - Oral cavity 1–4 0–3 5–10 MHz Preoperative 0.948
Kurokawa et al. (37) Japan 2000–2003 Prospective 28 59,4 64% Tongue 1–4 1–2 7.5 MHz Preoperative 0.976
Shintani et al. (38) Japan - Prospective 39 58 64% Oral cavity 1–4 0–2 7.5 MHz Preoperative 0.99
US, ultrasonography. Fom, floor of mouth.
The MR1 model resulted as statistically significant (P < 0.001).
The forest plot of the MR1 model is reported in Figure 2,
while the plots for evaluating publication bias and heterogeneity
are shown in Figure 3. Egger’s test for funnel plot asymmetry
(Figure 3A) did not reach statistical significance (P = 0.563),
while all studies remained within the confidence region of the Q-
Q plot (Figure 3B). The Baujat plot showed that the study of Goel
et al. (21) provided the greatest contribution to heterogeneity
(Figure 3D). By entering the main variables (patient mean age
and sex, tumor site, T, N, M, TT/DOI) as moderators in the
MR1model, only patientmean age reached statistical significance
(P = 0.04).
In the random-effects model with only MR studies (n =
8) that evaluated TT (MR2 model), the I2 was 95.47% (95%
CI, 86.74–98.57), and the H2 was 22.08 (95% CI, 7.54–70.09),
with Q = 154.556 (P < 0.001). The pooled r was 0.87
(95% CI, 0.82–0.93), whereas the pooled r-to-z transformed
was 1.46 (95% CI, 0.99–1.92). The MR2 model resulted as
statistically significant (P < 0.001). The forest plot of the
MR2 model is reported in Figure S1, while the plots for
evaluating publication bias and heterogeneity are shown in
Figure S2. Also in the RM2 model, Egger’s test for funnel plot
asymmetry (Figure S2A) did not reach statistical significance
(P = 0.601), while the study of Goel et al. (21) provided
the greatest contribution to heterogeneity (Figure S2D). By
entering moderators in the MR2 model as described above,
only patient mean age reached statistical significance (P
= 0.019).
Meta-Analysis for Studies Related to
Intraoral US
In the random-effects model with all intraoral US studies (n =
12) included (US1 model), the I2 was 93.56% (95% CI, 85.03–
97.50), and the H2 was 15.53 (95% CI, 6.68–40.06), with Q =
170.884 (P < 0.001). The pooled r was 0.96 (95% CI, 0.94–0.97),
whereas the pooled r-to-z transformed was 1.76 (95% CI, 1.39–
2.13). The US1 model resulted as statistically significant (P <
0.001). The forest plot of the US1 model is reported in Figure 4,
while the plots for evaluating publication bias and heterogeneity
are shown in Figure 5. Egger’s test for funnel plot asymmetry
(Figure 5A) did not reach statistical significance (P = 0.779),
while all studies remained within the confidence region of the
Q-Q plot (Figure 5B). The Baujat plot showed that the studies
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TABLE 3 | Application of the quality assessment of diagnostic accuracy studies (QUADAS)-2 for each included study.












Moreno et al. (20) ? L L L ? L L
Goel et al. (21) ? L L L ? L L
Yesuratnam et al. (19) H L L L L L L
Chen et al. (22) L L L L L L L
Park et al. (23) L L L L L L L
Lwin et al. (24) H L L L H L L
Jung et al. (25) L L L L L L L
Okura et al. (26) ? ? L H ? ? L
Lam et al. (27) L ? L L L ? L
US
Iida et al. (28) L ? L ? L ? L
Yesuratnam et al. (19) H L L L L L L
Chammas et al. (29) ? L L L ? L L
Lodder et al. (30) L H L H L H L
Kodama et al. (31) ? L L L ? L L
Mark Taylor et al. (32) ? L L ? ? L L
Kaneoya et al. (33) ? L L ? ? L L
Baek et al. (34) L ? L L L ? L
Yamane et al. (35) L ? L L L ? L
Songra et al. (36) L L L L L L L
Kurokawa et al. (37) H ? L L H ? L
Shintani et al. (38) H ? L ? H ? L
MR, magnetic resonance; US, ultrasonography H, high risk; L, low risk; ?, uncertain.
FIGURE 2 | Forest plot for r-to-z transformation in the random-effects model
with included studies related to magnetic resonance (MR1 model).
of Baek et al. (34), Yamane et al. (35), and Shintani et al. (38)
provided the greatest contribution to heterogeneity (Figure 5D).
By entering the main variables (patient mean age and sex, tumor
site, T, N, M, TT/DOI, probe) as moderators in the US1 model,
patient sex (P = 0.006) and probes at 12 MHz (P = 0.005), 5–15
MHz (P = 0.002), 8–10 MHz (P = 0.003), and 5–10 MHz (P =
0.033) reached statistical significance.
In the random-effects model with only intraoral US studies
(n = 11) that evaluated TT (US2 model), the I2 was 93.76%
(95% CI, 84.69–97.67), and the H2 was 16.03 (95% CI, 6.53–
42.95), with Q = 160.321 (P < 0.001). The pooled r was 0.96
(95% CI, 0.95–0.98), whereas the pooled r-to-z transformed was
1.80 (95% CI, 1.40–2.20). The US2 model resulted as statistically
significant (P < 0.001). The forest plot of the US1 model is
reported in Figure S3, while the plots for evaluating publication
bias and heterogeneity are shown in Figure S4. Also in the
US2 model, Egger’s test for funnel plot asymmetry (Figure S4A)
did not reach statistical significance (P = 0.892), while the
studies of Yesuratnam et al. (19), Baek et al. (34), and Shintani
et al. (38) provided the greatest contribution to heterogeneity
(Figure S4D). By entering moderators in the US2 model as
described above, patient sex (P = 0.005) and probes at 12 MHz
(P = 0.005), 5–15 MHz (P = 0.002), 8–10 MHz (P = 0.003), and
5–10 MHz (P = 0.033) reached statistical significance.
DISCUSSION
To the best of our knowledge, this is the first systematic review
with meta-analysis of the literature that compares the accuracy of
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FIGURE 3 | Plots for evaluating publication bias and heterogeneity in the random-effects model with included studies related to magnetic resonance (MR1 model). (A)
funnel plot; (B) radial plot; (C) normal quantile–quantile plot; (D) Baujat plot.
MR and intraoral US in the measurement of TT and/or DOI in
oral SCC. Nevertheless, this topic merits considerable attention
due to the well-recognized role of DOI as a prognosticator in
terms of oncological outcomes during and after management
of oral cancer. To choose the most appropriate therapy for
such tumors, in fact, two fundamental issues must be carefully
taken into account: the longitudinal extension in depth and
involvement of the extrinsic tongue musculature. Before the
introduction in clinical practice of the 8th edition of the TNM
staging system, TT was the most common measure used to
assess the longitudinal extension in depth of oral cavity tumors.
Different authors recently underlined the correlation between
DOI and TT, showing that, even though the two concepts
are quite different, the T category and TNM stage prognostic
performances within the 8th edition of the TNM are similar
regardless of whether DOI or TT is used as a T-category modifier
(39). Furthermore, it has been demonstrated that both TT and
DOI are highly correlated with nodal risk but with different cutoff
points for prediction (40). However, DOI is nowadays considered
as the most reliable parameter, better correlating with the risk of
nodal metastasis and patient prognosis. In spite of this, authors
enrolled in the present meta-analysis articles referring to both
DOI and TT because the aim of the study was to investigate the
tools’ accuracy in measuring linear spatial dimensions in relation
to the histopathological standards, rather than attributing any
oncological value to any of these two variables.
The second important detail to be evaluated is the possible
involvement of the extrinsic tongue muscles that are in close
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FIGURE 4 | Forest plot for r-to-z transformation in the random-effects model
with included studies related to intraoral ultrasonography (US1 model).
relationship (in the range of a few millimeters) with the
mucosa overlying the floor of the mouth and the posterior-
lateral portion of the lingual body. In such a case, the risk
of in-transit metastases along the T-N tract is consistently
high (41). The T-N tract is represented by the sublingual
and submandibular glands, mylohyoid muscle, lingual nerve,
artery and vein, and all the stromal tissue, and lingual and
sublingual lymph nodes of the compartment: all these structures
are anatomically present between the tongue (T) and the first
lymph node level (N) in the neck. The T-N tract plays an
important role in prognosis and survival in patients with tongue
and floor-of-the mouth cancer (42). Hence we can assume that
when extrinsic muscles are not involved by the tumor, usually
for T1–T2 with DOI < 10mm (3), the lesion can be safely
removed transorally. On the other hand, in more advanced
stages, the paradigm shift from circumferential and/or cuneiform
to longitudinal compartmental resection allows obtaining the
best loco-regional control (41, 43). DOI, particularly for early-
intermediate lesions (cT1–T2N0), is crucial in deciding whether
to perform a simultaneous neck dissection or defer it after formal
histopathological evaluation raising the doubt of a higher risk
for occult nodal metastasis (18, 19). It is well-established, in fact,
that DOI is strictly related to the probability of having occult
nodal metastases in regional lymph nodes. Mohit-Tabatabai et al.
(44) and Spiro et al. (45) first applied Breslow’s hypothesis (46)
regarding an existent link between lymph node involvement
and DOI in oral SCC. However, till now, controversy still
persists about the optimal DOI cutoff for a clinically relevant
risk of occult nodal disease. Several studies in the literature
concluded that such an optimal cutoff point could be set at 4
mm: therefore, in cN0 patients with DOI < 4mm, an elective
neck dissection could in theory be safely spared (20, 24, 26, 27).
Even though histological determination of DOI is so far the gold
standard in the decision-making process of performing or not
performing prophylactic neck dissection for early oral tongue
SCC, its accurate preoperative measurement allows performing
such an elective surgical procedure simultaneously with tumor
excision only in selected cases, thus reducing the number of
undue overtreatments.
Nowadays, MR remains the most precise tool for oral SCC
loco-regional staging, with a reported sensitivity of 94% (47). The
best MR sequence to define DOI is considered to be T1-weighted
contrast-enhanced. On the other hand, a T2-weighted sequence
overestimates tumor volume, since peritumoral inflammation
and edema cannot be distinguished from the actual tumor. In
fact, tumor, peritumoral edema, and inflamed tissues show the
same T2 repetition times, while T1-weighted sequence allows a
more affordable distinction between them.
Singh et al. (48) reported good agreement (k value of 0.790)
for T staging between MR and definitive histopathological
evaluation, with the final pT category changed in only 14%
of their patients. Furthermore, Moreno et al. (20) recently
reported their experience in using 3.0 T MR for oral tongue
carcinoma staging: the increased signal-to-noise ratio and
larger susceptibility resulted in higher spatial resolution, leading
to improved imaging, and diagnostic strength. The primary
objective of their study was to evaluate the efficacy of the 3.0 T
MR in predicting TT of oral SCC compared with histological
measures. The secondary end point was to compare radiographic
and pathological nodal staging, evaluating the relationship
between TT of oral SCC and the presence of cervical lymph
node metastasis, and to assess the capacity of the 3.0 T machine
to predict extracapsular extension. In their series, TT at MR
was always significantly higher than the histological value, with
a Pearson correlation coefficient of 0.81. By contrast, 3.0 T
MR seems to have a higher sensitivity (83.3%), specificity
(81.8%), and accuracy (82.3%) than the 1.5 T MR in predicting
nodal metastasis.
Baek et al. (34) recently confirmed the usefulness of intraoral
US in predicting pathologic TT of oral tongue SCC. Moreover,
they underlined how both CT and MR have some limitations
in evaluation of tongue cancers, with MR providing superior
information over CT in what concerns soft tissues. Yesuratman
et al. (19) found that preoperative intraoral US demonstrated a
high correlation with histopathological TT (r = 0.80), while MR
only a moderate one (r = 0.69). Furthermore, they identified
biopsy performed before imaging as a significant confounding
factor in reducing the accuracy of preoperative imaging. Intraoral
US and MR were, in fact, unable to differentiate post-biopsy
hematomas from squamous dysplasia and/or invasive SCC. In
this scenario, intraoral US seems especially useful in discerning
structures of crucial soft tissues. The possibility tomove the probe
along different planes, even through the skin of the face if needed,
and to ask the patient to protrude andmove the tongue or swollen
cheek, are simple but effective tools used to evaluate thin muscles
and buccal fat layers. However, due to the heterogeneity of the
instrumentation used in the selected studies, the best probe, as
well as the ideal PF and modality to be used for the examination,
is still to be defined. In this respect, Iida and coworkers (28)
reported a T-shape linear probe fitted with a rubber sheath
and filled with water as an ideal tool to preoperatively measure
DOI. The aforementioned features, however, allow the surgeon
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FIGURE 5 | Plots for evaluating publication bias and heterogeneity in the random-effects model with included studies related to intraoral ultrasonography (US1
model). (A) funnel plot; (B) radial plot; (C) normal quantile–quantile plot; (D) Baujat plot.
to better delineate the actual three-dimensional extension of the
disease, especially considering that intraoral US may be repeated
in the operatory room, just before surgery; it also may be used
intraoperatively to check the resection margins and even ex vivo
on the resected specimen (34, 36, 49).
The main limitation of intraoral US is the impossibility of
reaching some oral subsites and the impediment given by bony
structures: in fact, lesions located in the posterior third of
the mobile tongue are not easily accessible to a perpendicular
evaluation. Furthermore, when performing intraoral US, the
probe should be kept in tight contact with the organ to be
evaluated to improve the interface between them, but without
exerting too much pressure that could deform or modify
the shape of the neoplasm itself. As an intrinsic limit of
this technique, intraoral US is a strongly operator-dependent
live examination: as a consequence, different radiologists with
variable experiences may report different information. Moreover,
the same exam cannot be reassessed by a second operator at a
later time.
Both MR and intraoral US were shown herein to have
good correlation with histopathological findings. Nonetheless,
the higher pooled r was seen in the intraoral US studies (0.96
vs. 0.87), even though more research is needed to standardize
the optimal PF. On the top of this, however, intraoral US was
a better preoperative and intraoperative predictor of TT and
DOI, particularly in early SCC located in the anterior part of the
oral cavity.
Limitations of the Meta-Analysis
Although we performed extensive analyses and diagnostic plots
by using an open source environment, making our study
potentially reproducible (50), this review is affected by several
limitations. Potential weakness may have affected the review
process (unintentional omission of papers and/or impossibility
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to retrieve some). Although we did not find significant funnel
plot asymmetry for potential publication bias, by applying the
QUADAS-2, a high risk of bias occurred in three MR-related
studies (19, 24, 26) and in four US-related studies (19, 30,
37, 38), with an overall low quality assessment for both MR-
and US-related studies following the GRADE system. Moreover,
Cochrane’s Q was significant in all models evaluated in the meta-
analysis, suggesting a high heterogeneity of the pooled data.
These findings are likely to reflect several methodological “gray
zones” of the selected studies. Not all studies clearly specified if
a double-blinded exam evaluation process had been performed.
The period of enrollment ranged from 3 to 10 years among MR
studies, and from 2 to 7 years for those concerning intraoral
US. The probability that radiological techniques and operators
may have changed during this time frame is proportional to
the duration of the enrollment period. The number of cases
analyzed by each paper significantly diverged from 18 to 102
for MR and from 13 to 109 for intraoral US. The process of
patient selection significantly differed among the studies: six of
nine MR publications took into account T1–T4 patients (19–
21, 23, 24, 26), one study T1–T3 (27), one only T1–T2 (25), and
the last only T4a patients (22). Among the 12 intraoral US papers,
seven studies considered T1–T4 patients (19, 28, 29, 32, 36–
38), while five early-stage tumors (T1–T2) only (30, 31, 33–
35). In this regard, a larger discrepancy in measurements is
more probable to happen in T4 patients compared to flatter
and smaller lesions. Execution modality and evaluation of the
diagnostic exams were not always uniform among the considered
papers: different equipment was used; the timing between
imaging and histopathological examination, as well as between
preoperative biopsy and imaging, was inconstant or unexplained.
Furthermore, only one MR and one intraoral US study
considered DOI as a benchmark with histopathology. Finally,
although we conducted a meta-regression to detect whether
clinical variables influenced the results, some variables could not
be quantitatively detected. These included the diagnostic ability
of radiologists and individual, unreported clinical variables.
Inherent diversity among studies, small sample sizes, and other
unpredictable biases are all possible limitations.
CONCLUSIONS
Guidelines for diagnosis, treatment, and follow-up of head and
neck SCC consider MR as the preferred staging method for each
site and subsite except the larynx and hypopharynx (51). In
fact, it offers the best discrimination of soft tissues, contouring
of tumor borders, neoplastic extension, and identification of
intracranial and/or perineural spreads, and also enables the
radiologist to analyze intratumoral vascularization. On the
other hand, the limits of MR are mainly represented by the
impossibility to perform the examination in patients who
are claustrophobic, non-compliant, or with metallic prostheses
and pacemakers. Also, significant artifacts due to metallic
implants or other fixed prostheses may significantly hamper
the intraoral imaging quality. By contrast, intraoral US is
definitely faster, less invasive, and cost-effective, and requires
less patient compliance, and its high-resolution allows us to
better define TT and DOI in early-stage tumors of the mobile
tongue and buccal mucosa. However, it remains highly operator-
dependent and difficult to use for lesions in close continuity
with bony structures or located in the posterior part of the
oral cavity.
Considering the limitations of the studies included and
the retrospective nature intrinsic to any meta-analysis, further
prospective comparisons between intraoral US and MR in the
same cohort of patients are strongly recommended. This will
allow the identification of the best imaging technique to be
specifically used in early and advanced oral SCC, possibly
with a parallel reduction in terms of patient selection biases.
Nonetheless, from our data, it is possible to determine the non-
inferiority of intraoral US in comparison with MR. This will
allow clinicians to use a less expensive and faster tool in the
preoperative diagnostic workup of selected oral SCC, as well
as giving adjunctive information in case of doubtful results
after MR.
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